President Trump called Ukrainian President Volodymyr Zelenskyy a “dictator” in a social media post on Wednesday. The back-and-forth comes a day after the U.S. and Russia met to discuss a peace plan for the war in Ukraine. CBS News chief White House correspondent Nancy Cordes has more.
NFL fans usually use the phrase “frozen tundra” to describe the conditions at Lambeau Field in Green Bay, Wisconsin. But on Sunday night, it could have been used to describe the field at Highmark Stadium for the playoff game between the Buffalo Bills and Baltimore Ravens. Temperatures in Orchard Park, New York, fell to around…
The Uttarakhand Public Service Commission (UKPSC) has released the admit card for the UKPSC Upper PCS 2024 exam, available on their official website. Candidates can download the admit card by entering their login details. The exam will be held from February 2 to 5, 2025, in Haridwar and Haldwani. Visit the UKPSC website for updates…
Welcome to Fox News’ Politics newsletter with the latest political news from Washington D.C. and updates from the 2024 campaign trail. What’s happening… -Biden breaks Obama record for filling Federal Registers… -Elon Musk and Ron Paul agree on cutting foreign aid… -Laura Trump resigns from RNC as rumors of a Senate run swirl… Republican Iowa Sen….
One of two teenagers charged in the death of a retired police chief who they allegedly ran over as he was bicycling on a Las Vegas road has been found unfit to stand trial. Jesus Ayala, now 19, has been moved from jail to a secure Nevada psychiatric facility for evaluation, treatment and possible trial…
The U.S. Army confirmed Wednesday it is investigating the death of a U.S. soldier who died while stationed in Poland. Lt. Col. Joshua Camara, 45, was based at Camp Kościuszko, home of V Corps’ forward headquarters in the city of Poznan. He died on Tuesday, Sept. 3. A V Corps spokesperson said Camara was a…
The U.S. Food and Drug Administration (FDA) has approved a new drug for certain adult patients with endometrial cancer. Jemperli (dostarlimab-gxly) — made by British pharmaceutical company GSK — is intended for people with primary advanced or recurrent forms of the cancer, according to the FDA’s Aug. 1 announcement. It is an immunotherapy-based drug, which…